Absolutely Correct. REGN and AMGN have $ Billions. Buying ESPR is nothing vs. losing $ billions and $ billions in their cholesterol drugs
this is cheap
Biotech to see continued growth in 2015: HC Wainwright
by Mourad HaroutunianBoth Advaxis (NASDAQ:ADXS )Marque Investors ,Adage Capital Management and T. Rowe Price Associates invested nearly $17 million into Advaxis for 2015.